Prudential Jennison Health Sciences Fund Class B (PHLBX)

33.49
Net Asset Value
-0.06%
1 Day
-3.18%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
1.88%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund normally invests at least 80% of its investable assets in equity and equity-related securities of companies within the health sciences sector. It will invest in securities of issuers among a number of different countries throughout the world, one of which may be the United States. The portfolio managers use fundamental and quantitative analyses to select individual securities, and they may invest more than 5% of the fund's assets in any one issuer. The fund participates in the initial public offering (IPO) market. It is non-diversified.

Performance

1 month-15.45% 3 years+22.99%
3 months-11.45% 5 years+26.88%
1 year+25.64% Since inception+15.82%
Data through --

Peer Comparisonvs. Health

 PHLBXCategory
Performance 5-yr return+26.88%+23.71%
Expense ratio1.88%1.46%
Risk 5 year sharpe ratio1.491.54
Net assets$2.5B$2.6B
Average market cap$11.2B$31.7B
Average P/E27.726.8
Portfolio turnover54%54%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPrudential Investments
Fund manager & tenureDavid Chan / 14 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock75.94%
International stock16.32%
Cash5.83%
Fixed income1.91%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 97.95%
Consumer service 1.34%
Business service 0.00%
Consumer goods 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
BMRN Biomarin Pharmaceutical, Inc.5.18%
ALXN Alexion Pharmaceuticals, Inc.4.60%
VRTX Vertex Pharmaceuticals Inc4.23%
ICPT Intercept Pharmaceuticals Inc3.86%
INCY Incyte Corp Ltd3.77%
-- Roche Holding AG3.23%
BIIB Biogen Idec Inc3.07%
CLDX Celldex Therapeutics, Inc.2.81%
ISIS Isis Pharmaceuticals2.69%
HCA HCA Holdings Inc2.53%

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.